| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
|
McIntosh, Christopher H.S.
|
|
2005
|
128 |
2 |
p. 159-165
7 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2005
|
128 |
2 |
p. IFC-
1 p.
|
artikel
|
| 3 |
Festschrift for Werner Creutzfeldt
|
Unger, Roger H.
|
|
2005
|
128 |
2 |
p. 85-
1 p.
|
artikel
|
| 4 |
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
|
Hansotia, Tanya
|
|
2005
|
128 |
2 |
p. 125-134
10 p.
|
artikel
|
| 5 |
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
|
Nauck, Michael A.
|
|
2005
|
128 |
2 |
p. 135-148
14 p.
|
artikel
|
| 6 |
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
|
Larsen, Philip J.
|
|
2005
|
128 |
2 |
p. 97-107
11 p.
|
artikel
|
| 7 |
Glycaemic effects of incretins in Type 1 diabetes mellitus
|
Dupre, John
|
|
2005
|
128 |
2 |
p. 149-157
9 p.
|
artikel
|
| 8 |
The discovery of glucagon-like peptide 1
|
Lund, P. Kay
|
|
2005
|
128 |
2 |
p. 93-96
4 p.
|
artikel
|
| 9 |
The physiological role of GLP-1 in human: incretin, ileal brake or more?
|
Schirra, Jörg
|
|
2005
|
128 |
2 |
p. 109-115
7 p.
|
artikel
|
| 10 |
The [pre-] history of the incretin concept
|
Creutzfeldt, Werner
|
|
2005
|
128 |
2 |
p. 87-91
5 p.
|
artikel
|
| 11 |
What do we know about the secretion and degradation of incretin hormones?
|
Deacon, Carolyn F.
|
|
2005
|
128 |
2 |
p. 117-124
8 p.
|
artikel
|
Tijdschrift beschrijving